Chung Roger S, Penkowa Milena, Dittmann Justin, King Carolyn E, Bartlett Carole, Asmussen Johanne W, Hidalgo Juan, Carrasco Javier, Leung Yee Kee J, Walker Adam K, Fung Samantha J, Dunlop Sarah A, Fitzgerald Melinda, Beazley Lyn D, Chuah Meng I, Vickers James C, West Adrian K
NeuroRepair Group, Menzies Research Institute, University of Tasmania, Hobart, Tasmania 7001, Australia.
J Biol Chem. 2008 May 30;283(22):15349-58. doi: 10.1074/jbc.M708446200. Epub 2008 Mar 11.
A number of intracellular proteins that are protective after brain injury are classically thought to exert their effect within the expressing cell. The astrocytic metallothioneins (MT) are one example and are thought to act via intracellular free radical scavenging and heavy metal regulation, and in particular zinc. Indeed, we have previously established that astrocytic MTs are required for successful brain healing. Here we provide evidence for a fundamentally different mode of action relying upon intercellular transfer from astrocytes to neurons, which in turn leads to uptake-dependent axonal regeneration. First, we show that MT can be detected within the extracellular fluid of the injured brain, and that cultured astrocytes are capable of actively secreting MT in a regulatable manner. Second, we identify a receptor, megalin, that mediates MT transport into neurons. Third, we directly demonstrate for the first time the transfer of MT from astrocytes to neurons over a specific time course in vitro. Finally, we show that MT is rapidly internalized via the cell bodies of retinal ganglion cells in vivo and is a powerful promoter of axonal regeneration through the inhibitory environment of the completely severed mature optic nerve. Our work suggests that the protective functions of MT in the central nervous system should be widened from a purely astrocytic focus to include extracellular and intra-neuronal roles. This unsuspected action of MT represents a novel paradigm of astrocyte-neuronal interaction after injury and may have implications for the development of MT-based therapeutic agents.
许多在脑损伤后具有保护作用的细胞内蛋白质传统上被认为在表达细胞内发挥作用。星形胶质细胞金属硫蛋白(MT)就是一个例子,被认为通过细胞内自由基清除和重金属调节,特别是锌的调节来发挥作用。事实上,我们之前已经证实星形胶质细胞MT是脑成功愈合所必需的。在此,我们提供证据表明其作用方式与以往截然不同,即依赖于从星形胶质细胞向神经元的细胞间转移,进而导致依赖摄取的轴突再生。首先,我们表明在受伤脑的细胞外液中可以检测到MT,并且培养的星形胶质细胞能够以可调节的方式主动分泌MT。其次,我们鉴定出一种受体,巨膜蛋白,它介导MT转运进入神经元。第三,我们首次直接证明了在体外特定时间过程中MT从星形胶质细胞向神经元的转移。最后,我们表明MT在体内通过视网膜神经节细胞的胞体迅速内化,并且是通过完全切断的成熟视神经的抑制性环境促进轴突再生的强大促进剂。我们的工作表明,MT在中枢神经系统中的保护功能应从单纯关注星形胶质细胞扩展到包括细胞外和神经元内的作用。MT这种未被怀疑的作用代表了损伤后星形胶质细胞 - 神经元相互作用的新范式,可能对基于MT的治疗药物的开发具有重要意义。